Socio-economical aspects, quality of life and state of knowledge in hepatitis B patients - Socio-economical aspects in hepatitis B;Sozioökonomische charakteristika, lebensqualität und wissensstand bei patienten mit hepatitis-B-virusinfektion in Deutschland - Sozioökonomische aspekte bei hepatitis B

Zeitschrift fur Gastroenterologie

Volumn 45, Issue 5, 2007, Pages 355-358

  Niederau, Claus ^a,b,d   Fischer, C ^c   Kautz, A ^a  

^a Deutsche Leberhilfe eV   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c Gilead Sciences GmbH   (Germany)

^d Katholische Kliniken Oberhausen   (Germany)

Author keywords

Hepatitis B virus; Interferon; Liver biopsy; Liver cirrhosis; Quality of life; Ribavirin

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; DISEASE SEVERITY; FEMALE; GENDER; GENOTYPE; GERMANY; HEALTH INSURANCE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; INFECTION RISK; INFLAMMATION; INTERNET; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SOCIOECONOMICS; SUPPORT GROUP; VIRUS LOAD; AGE DISTRIBUTION; ATTITUDE TO HEALTH; METHODOLOGY; MIDDLE AGED; PATIENT; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT; RISK FACTOR; SEX RATIO; STATISTICS;

AGE DISTRIBUTION; FEMALE; GERMANY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPATITIS B; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION; PATIENTS; QUALITY OF LIFE; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS;

EID: 34447257432     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-963102     Document Type: Article

References (16)

1. Niederau C, Bemba G, Kautz A. Sozio-ökonomische Charakteristika, Lebensqualität und Wissensstand bei Patienten mit Hepatitis C-Virus-infektion in Deutschland. Zeitschr Gastroenterol 2006; 44: 305-317
2. Bullinger M, Kirchberger I. SF36 Fragebogen zum Gesundheitszustand. Göttingen: Hogrefe Verlag, 1998
3. Statistisches Bundesamt Deutschland. Statistisches Jahrbuch für die Bundesrepublik Deutschland 2006. ISBN-13: 978-3-8246-0773-0. Daten auch als PDF-Datei unter www.destatis.de
4. Marschall T, Kramer A, Prufer-Kramer L et al. Does migration from high and intermediate endemic regions increase the prevalence of hepatitis B infection in Germany? Dtsch Med Wochenschr 2005; 130: 2753-2758
5. Heintges T, Niederau C, Mohr L et al. Epidemiologie und Klinik der chronischen Virushepatitis. Dtsch Med Wochenschr 1994; 119: 1365-1370
6. RKI. Epidemiologisches Bulletin 17, November 2006 /Nr. 46 Aktuelle Daten und Informationen zu Infektionskrankheiten und Public Health. Virushepatitis B, C und D: Situationsbericht
7. Deutschland 2005. Lindenberg: Plusprint Verlag, 2006: 399-410. Daten auch als PDF-Datei unter www.rki.de
8. Marcellin P, Lau G, Piratvisuth T et al. Better safety and quality of life in patients with chronic hepatitis B than in patients with chronic hepatitis C when treated with peginterferon alfa-2a monotherapy. Hepatology 2004; 40: 668A
9. Younossi ZM, Boparai N, Price LL et al. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol 2001; 96: 2199-2205
10. Wu GC, Zhou WP, Zhao YR et al. Long-term health-related quality of life in chronic hepatitis B patients. Zhonghua Gan Zang Bing Za Zhi 2003; 11: 275-277
11. Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C infection causes a significant reduction in HRQOL in the absence of cirrhosis. Hepatology 1998; 27: 209-212
12. Pojoga C, Dumitrascu DL, Pascu O et al. Impaired health-related quality of life in Romanian patients with chronic viral hepatitis before antiviral therapy. Eur J Gastroenterol Hepatol 2004; 16: 27-31
13. Dickson RC, Wright RM, Bacchetta MD et al. Quality of life of hepatitis B and C patients after liver transplantation. Clin Transplant 1997; 11: 282-285
14. Manns MP, Wedemeyer H, Meyer S et al. German Society for Alimentary Metabolic Disorders. Hepatitis Competence Network. Diagnosis, progression and therapy of hepatitis-B-virus infection: results of an evidenced based consensus conference of the German Society for Alimentary Metabolic Disorders and in cooperation with the Hepatitis Competence Network. Z Gastroenterol 2004; 42: 677-678
15. The EASL Jury. Consensus statement. EASL International Consensus Conference on Hepatitis B. J Hepatol 2003; 39: 3-25
16. Rambaldi A, Jacobs BP, Iaquinto G et al. Milk thistle for alcoholic and/or hepatitis B or C liver diseases - a systematic cochrane hepato-biliary group review with meta-analyses of randomized clinical trials. Am J Gastroenterol 2005; 100: 2583-2591